Skip to main content

Table 3 Performance of iELISA using rOmp2a antigen

From: Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis

S.No.

Group

Positive by iELISA

Negative by iELISA

1

I

14(93.3%)

1(6.66%)

2

II

23(82.1%), 25(96.1%)

5(17.8%), 1(3.8%)

3

III

1(3.8%), 3(9.37%)

25(96.1%), 29(90.6%)

4

IV

2(5.7%)

33(94.2%)

5

V

1(4.3%)

22(95.6%)